15, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the US In Vitro Diagnostics Market is projected to grow from about USD 37.43 Billion in 2025 to USD 57.18 billion by 2031, at a CAGR of 7.3% ... US In Vitro Diagnostics Market Size & Forecast.
STEMart introduces In Vitro Micronucleus Test service to meet the genotoxicity testing requirements for medical devices ... The in vitro micronucleus (MNvit) test is a genotoxicity assay that detects micronuclei in the cytoplasm of interphase cells.
The legislation codifies President Trump’s agenda but includes a few measures challenging his policies and insisting on more consultation with Congress... .
The global In Vitro Diagnostics (IVD) Market, valued at US$100,769.3 million in 2024, is poised for strong expansion, reaching US$109,065.5 million in 2025 and an impressive US$157,632.5 million by 2030 at a 7.6% CAGR.
). MedTech Europe has created a specific classification scheme for In Vitro Diagnostics (IVDs), the GlobalIVD (GIVD) classification (previously known as EDMA classification) ... The updated 2026 GIVD Classification is now also available ... Disclaimer.
In-Vitro Fertilization (IVF) MarketOverview.. The global In-Vitro Fertilization (IVF) market is poised to experience robust growth, with an anticipated compound annual growth rate (CAGR) of 9% through 2029.